MedPath

仁合益康集团有限公司

Ownership
-
Established
2018-06-08
Employees
-
Market Cap
-
Website
http://www.rhykjt.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

73

NMPA:73

Drug Approvals

Procaterol Hydrochloride Oral Solution

Product Name
盐酸丙卡特罗口服溶液
Approval Number
国药准字H20254528
Approval Date
Jun 10, 2025
NMPA

Multiple Electrolytes, Sodium Acetate and Glucose Injection

Product Name
复方电解质醋酸钠葡萄糖注射液
Approval Number
国药准字H20254089
Approval Date
May 13, 2025
NMPA

Multiple Electrolytes, Sodium Acetate and Glucose Injection

Product Name
复方电解质醋酸钠葡萄糖注射液
Approval Number
国药准字H20254088
Approval Date
May 13, 2025
NMPA

Sodium Acetate Ringer’s and Glucose Injection

Product Name
醋酸钠林格葡萄糖注射液
Approval Number
国药准字H20253988
Approval Date
Apr 22, 2025
NMPA

Magnesium Sulfate,Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution

Product Name
硫酸镁钠钾口服用浓溶液
Approval Number
国药准字H20253996
Approval Date
Apr 22, 2025
NMPA

Dobutamine Hydrochloride Injection

Product Name
盐酸多巴酚丁胺注射液
Approval Number
国药准字H20253654
Approval Date
Mar 18, 2025
NMPA

Nitroglycerin Injection

Product Name
硝酸甘油注射液
Approval Number
国药准字H20253572
Approval Date
Mar 11, 2025
NMPA

Nitroglycerin Injection

Product Name
硝酸甘油注射液
Approval Number
国药准字H20253571
Approval Date
Mar 11, 2025
NMPA

Procaterol Hydrochloride Inhalation Solution

Product Name
盐酸丙卡特罗吸入溶液
Approval Number
国药准字H20253558
Approval Date
Mar 4, 2025
NMPA

Furosemide Oral Solution

Product Name
呋塞米口服溶液
Approval Number
国药准字H20253554
Approval Date
Mar 4, 2025
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.